<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00210067</url>
  </required_header>
  <id_info>
    <org_study_id>06-101</org_study_id>
    <nct_id>NCT00210067</nct_id>
  </id_info>
  <brief_title>A Study in Subjects With Retinal Detachment</brief_title>
  <official_title>A Double-Masked, Randomized, Dose-Ranging Study of a Single Intravitreal (IVT) Injection of INS37217 Intravitreal Injection in Subjects With Retinal Detachment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Merck Sharp &amp; Dohme Corp.</source>
  <brief_summary>
    <textblock>
      The purpose of this trial is to access the tolerability of INS37217 Intravitreal Injection
      when administered intravitreally in subjects with macula-on or macula-off rhegmatogenous
      retinal detachment (RRD).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2001</start_date>
  <completion_date type="Actual">June 2002</completion_date>
  <primary_completion_date type="Actual">June 2002</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>tolerability</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>pharmacological activity</measure>
  </secondary_outcome>
  <enrollment type="Actual">14</enrollment>
  <condition>Retinal Detachment</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>denufosol tetrasodium (INS37217) Intravitreal Injection</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  have macula-on or macula-off rhegmatogenous retinal detachment

          -  are eligible for pneumatic retinopexy, with identifiable retinal breaks

          -  are phakic or pseudo-phakic

        Exclusion Criteria:

          -  have detachments not of a rhegmatogenous nature

          -  currently have blood in the vitreous, corneal opacity, or other conditions which limit
             the view of peripheral retina

          -  have evidence of intraocular inflammation (uveitis)

          -  have a history of current condition of uncontrollable, elevated IOP or open-angle
             glaucoma

          -  have breaks not conducive to a single procedure of pneumatic retinopexy treatment

          -  have proliferative vitreoretinopathy of type C or D

          -  have previously had a vitrectomy or require one

          -  have previously had a scleral buckle procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Amy Schaberg, BSN</last_name>
    <role>Study Director</role>
  </overall_official>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2005</study_first_posted>
  <last_update_submitted>October 8, 2015</last_update_submitted>
  <last_update_submitted_qc>October 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dissociative Disorders</mesh_term>
    <mesh_term>Retinal Detachment</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

